Powering affordable care

through early identification of chronic kidney disease

Request Information

37 million Americans have CKD¹

9 out of 10 people with CKD don’t know they have it¹

Featured resources

Quality Reporting: Test Code Reference Guide

Improve quality metrics by closing the gap in care with chronic kidney disease testing

The Test Code Reference Guide aims to drive patient outcomes while helping you optimize reimbursement. Access the guide for more on testing that supports your chronic kidney disease quality metrics reporting.

Learn more

CKD Risk Map

Risk stratify patients using the Kidney Profile with enhanced reporting

To aid your practice, the National Kidney Foundation and the Kidney Disease: Improving Global Outcomes (KDIGO) initiative have developed a risk map and follow-up testing guideline.

Access the CKD risk map

CKD White Paper

Top 5 questions primary care physicians ask about chronic kidney disease testing

Our medical experts explain why serum creatinine with estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (uACR) testing must be used together to diagnose and monitor CKD, among other topics.

Download White Paper

CKD Webinar

The Continuum of Chronic Kidney Disease Care: From Identification to Referral

Find out how early identification of risk can help you get ahead of chronic kidney disease.

Get ahead of chronic kidney disease

Use this form to request information and resources from your Quest representative.

First Name* Last Name* Email Address* ZIP Code* Practice* Title Business Phone

*Required fields

Sign me up for updates Please have a Quest Diagnostics sales representative contact me to discuss testing options

Request Information

Bridge the gap in CKD testing

The majority of patients at risk for CKD are not receiving the recommended testing.^14,15 Guideline-based monitoring with the Quest Diagnostics Kidney Profile offers enhanced reporting that empowers primary care providers to:

Easily interpret results

Determine follow-up testing frequency

Identify risk earlier

Put your patients on a path to better health

Low risk: monitor yearly if evidence of kidney damage (eg, indicated by imaging or biopsy)

Moderately high risk: monitor yearly

High risk: monitor 2 times yearly

Very high risk: monitor 3 times yearly

Very high risk: monitor 24 times yearly

The National Kidney Foundation and Kidney Disease: Improving Global Outcomes (KDIGO) Initiative recommend a frequency of monitoring CKD based on Serum Creatinine with effective Glomerular Filtration Rate (eGFR) and Urine Albumin-Creatinine Ratio (uACR).

Test Name	Kidney Profile
Test Description	This Profile combines 2 common tests—eGFR and uACR—to support early detection of CKD. This profile supports the National Kidney Foundation initiative to drive adoption of such protocols to facilitate appropriate test ordering to address early detection of CKD.
Test Code	39165
CPT	82043, 82565, 82570
Preferred Specimen	1 mL serum and 10 mL random urine collected in plastic urine container
Alternative Specimen	Serum Separator Tube (SST^®) and Plastic urine container
Transport Tempature	Refrigerated (cold packs)
Specimen Stability	Room tempature: 7 days; Refrigerated: 7 days; Frozen: 28 days

Get the insights you need to get ahead of CKD

Request more information from your Quest representative

Request Information

New customer? Sign up to be contacted by your local Quest representative

Powering affordable care through guideline-based testing

Quest is committed to supporting you with the guideline-based testing and resources you need to guide your patients’ kidney health

Test Name	Test Description	Test Code	CPT Code(s)
Kidney Profile*	Creatinine (includes eGFR) Albumin, Random Urine with Creatinine (includes Albumin/Creatinine Ratio)	39165	82043, 82565, 82570
Cystatin C with eGFR	Marker of renal function, Cystatin C is a low molecular weight protein that, like creatinine, is freely filtered by kidneys	94588	82610

*Panel components 6517-Albumin, Random Urine with Creatinine; 375-Cratinine, Serum: Panel components may be ordered separately.

References:

CDC. Chronic kidney disease in the United States, 2021. Updated March 4, 2021. Accessed April 2, 2021. https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html
National Kidney Foundation. Laboratory medicine impact on population health implementing the kidney profile. https://www.kidney.org/sites/default/files/02-11-8160_hbj_cmo_ascp_poster3.pdf.
National Kidney Foundation. CKDIntercept Laboratory Engagement Initiative. https://www.kidney.org/CKDintercept/laboratoryengagement

The CPT codes provided are based on American Medical Association guidelines and are for informational purposes only, CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
Image content features models and is intended for illustrative purposes only.